Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02657421 · ClinicalTrials.gov registry record
OLIF25™ /OLIF51™ Study
A clinical trial, sponsored by Medtronic Spinal and Biologics.
- Terminated
- Registry status
- 168
- Enrollment target
NCT02657421: Clinical Trial study, sponsored by Medtronic Spinal and Biologics.
NCT02657421 is a clinical trial that was terminated before completion, run by Medtronic Spinal and Biologics. The registered enrollment target is 168 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02657421 was terminated before completion, sponsored by Medtronic Spinal and Biologics.
- TERMINATED
- Registry status
- 168 participants
- Enrollment target
Study Summary
The purpose of this single-arm observational study is to observe and document clinical outcomes of the OLIF25™ and OLIF51™ procedures in patients diagnosed with degenerative disc disease or degenerative scoliosis, and report the rate of adverse events of interest through the 24 months follow-up visit.
Interventions
- PROCEDURE Oblique Lateral Interbody Fusion
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 168 participants |
| Start Date | 2015-11 |
| Est. Completion | 2018-05-03 |
Why NCT02657421 stopped before completion
NCT02657421 is an observational study that tracks outcomes without assigning an intervention. The registered 168 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Oblique Lateral Interbody Fusion is the first listed.
NCT02657421 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02657421 about?
NCT02657421 is a clinical study titled "OLIF25™ /OLIF51™ Study". The purpose of this single-arm observational study is to observe and document clinical outcomes of the OLIF25™ and OLIF51™ procedures in patients diagnosed with degenerative disc disease or degenerative scoliosis, and report the rate of adverse events of interest through the 24 months follow-up visi...
What is the current status of trial NCT02657421?
This trial is currently terminated. The enrollment target is 168 participants. The study started on 2015-11. Estimated completion is 2018-05-03.
What interventions are being tested in trial NCT02657421?
The interventions under investigation include: Oblique Lateral Interbody Fusion (PROCEDURE).
Who is sponsoring clinical trial NCT02657421?
This trial is sponsored by Medtronic Spinal and Biologics, which has 26 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02118922 · 168 participants
A Study to Test the Diagnostic Potential of Brillouin Microscopy for Corneal Ectasia
- NCT03536897 · 168 participants
IORT Following Breast Conserving Surgery for Early Stage Breast Cancer Registry
- NCT04078230 · 168 participants · NA
Regional or Extend LymphAdenectomy During Resection of Intrahepatic Cholangiocarcinoma
- NCT04159168 · 168 participants · NA
Facial Affect Sensitivity Training for Young Children With Callous-unemotional Traits
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia